Andrew G Gillard1,2, Dong Ho Shin1,2, Lethan A Hampton1

  • 1Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

概括

质母细胞瘤 (GBM) 免疫疗法面临由于治疗耐药性的挑战. 了解天生的免疫机制是开发有效的脑瘤疗法和改善患者生存率的关键.